Comparing Zocor vs Alirocumab
Zocor | Alirocumab |
|
---|
Zocor (simvastatin) | Alirocumab |
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol - Familial Homozygous, High Cholesterol - Familial Heterozygous, Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa -... View more |
Prescription only
Prescribed for High Cholesterol - Familial Heterozygous, Cardiovascular Risk Reduction, High Cholesterol, High Cholesterol - Familial Homozygous. alirocumab may also be used for purposes not listed... View more |
Related suggestions High Cholesterol
Cardiovascular Risk Reduction
High Cholesterol, Familial Homozygous
Popular comparisons
|
|||||||
More about Zocor (simvastatin) | More about Alirocumab | ||||||||
Ratings & Reviews | |||||||||
Zocor has an average rating of 5.0 out of 10 from a total of 22 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 50% reported a negative effect. |
Alirocumab has an average rating of 6.3 out of 10 from a total of 291 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 32% reported a negative effect. |
||||||||
Drug Class | |||||||||
Side Effects | |||||||||
See also: Zocor side effects in more detail. |
See also: alirocumab side effects in more detail. |
||||||||
Generic Availability | |||||||||
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | |||||||||
View all Zocor prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Form(s) Available | |||||||||
|
N/A |
||||||||
Brand Names | |||||||||
Other simvastatin brands include: FloLipid | Praluent | ||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | |||||||||
N/A |
480 hours |
||||||||
CSA Schedule ** View glossary of terms | |||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | |||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | |||||||||
A total of 311 drugs are known to interact with Zocor:
|
A total of 2 drugs are known to interact with alirocumab:
|
||||||||
Alcohol/Food/Lifestyle Interactions | |||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
Disease Interactions | |||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|||||||||
First Approval Date | |||||||||
December 23, 1991 |
July 24, 2015 |
||||||||
WADA Class View World Anti-Doping Agency classifications. | |||||||||
N/A |
N/A |
||||||||
More Information | |||||||||
Patient resources | |||||||||
Professional Resources | |||||||||
Related Treatment Guide | |||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.